Device Trial Radar · NCT02878629
Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas
Last checked: Nov 19, 2026Latest source record: Aug 28, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
254
Actual
Start
Jul 2016
Primary completion
Aug 2019
Study completion Aug 2019
Sponsor
- Lead sponsor
- ONIRISNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 25, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective is to evaluate middle term compliance (≥ 2 years) of the Mandibular Advancement Devices Tali® in patients with Syndrome of Obstructive Sleep Apnea and Hypopneas.
Conditions
- Syndrome of Obstructive Sleep Apnea and Hypopneas
Interventions
Mandibular Advancement DevicesDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- compliance (no stop of the Mandibular Advancement Device)Time frame: 2 years or more after the beginning of device
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Liberal cabinet
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.